
-
Fighter jets, refuelling aircraft, frigate: UK assets in Mideast
-
Iranian Nobel laureates, Cannes winner urge halt to Iran-Israel conflict
-
Struggling Gucci owner's shares soar over new CEO reports
-
Khamenei, Iran's political survivor, faces ultimate test
-
Ireland prepares to excavate 'mass grave' at mother and baby home
-
France shuts Israeli weapons booths at Paris Air Show
-
Iran and Israel exchange deadly strikes in spiralling air war
-
Ex-England captain Farrell rejoins Saracens from Racing 92
-
UN slashes global aid plan over 'deepest funding cuts ever'
-
Sri Lanka's Mathews hails 'dream run' in final Test against Bangladesh
-
Former England captain Farrell rejoins Saracens from Racing 92
-
Olympic champ Ingebrigtsen's father acquitted of abusing son
-
Maria climbs 43 places in WTA rankings after Queen's win
-
Iran hits Israel with deadly missile onslaught
-
German court jails Syrian 'torture' doctor for life
-
Oil prices fall even as Israel-Iran strikes extend into fourth day
-
Scientists track egret's 38-hour flight from Australia to PNG
-
Los Angeles curfew to continue for 'couple more days': mayor
-
Iran hits Tel Aviv after overnight Israeli strikes on Tehran
-
China factory output slows but consumption offers bright spot
-
G7 confronts Israel-Iran crisis as Trump dominates summit
-
Relatives wait for remains after Air India crash
-
China factory output slumps but consumption offers bright spot
-
Record-breaking Japan striker 'King Kazu' plays at 58
-
Trump lands in Canada as G7 confronts Israel-Iran crisis
-
Oil prices rise further as Israel-Iran extends into fourth day
-
Olympic champ Ingebrigtsen's father set for abuse trial verdict
-
German court to rule in case of Syrian 'torture' doctor
-
Trump orders deportation drive targeting Democratic cities
-
Spaun creates his magic moment to win first major at US Open
-
Royal Ascot battling 'headwinds' to secure foreign aces: racing director
-
Spaun wins US Open for first major title with late birdie binge
-
Israel pounds Iran, Tehran hits back with missiles
-
'Thin' chance against Chelsea but nothing to lose: LAFC's Lloris
-
PSG cruise over Atletico, Bayern thrash Auckland at Club World Cup
-
G7 protests hit Calgary with leaders far away
-
USA end losing streak with crushing of hapless Trinidad
-
UK appoints Blaise Metreweli first woman head of MI6 spy service
-
One dead after 6.1-magnitude earthquake in Peru
-
Xtra Energy Corp. and SD&T Associates Ltd. Acquire Stibnite Prospect and Antimony Queen Mine, Marking Major Expansion in XTPT's Strategic U.S. Antimony Portfolio
-
Inovatec to Preview Funding Automation Module at Canada's Used Car Week
-
Aeonian Resources Reports Highly Anomalous Copper Assay Results from Surface Sampling Program at Koocanusa Project, Southeast British Columbia
-
WidePoint Awarded 3-Year External Certification Authority (ECA) Token Certificate Contract to Leading Aerospace & Defense Contractor
-
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August
-
Allbridge's 'Skyway with Allbridge Intelligence' Delivers Smarter, Faster and Easier Property Technology Management
-
Passing the Torch: A Legacy of Leadership at the Gaston Community Foundation
-
Shawn's Property Management Ltd. Wins 9th Consumer Choice Award for Property Management Excellence in Regina
-
1933 Industries Reports Profit in Third Quarter 2025 Financial Results
-
Ondas' American Robotics Secures Purchase Order from a Major Urban Public Safety Organization in the U.S. for the Kestrel System, an Advanced Drone Detection and Counter-UAS Solution
-
American Resources Corporation and ReElement Technologies Corporation Announces Updated Participation in June Industry Conferences

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform
LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the companies are exploring options to integrate the early detection of dementia into Ainnova's proprietary, AI-powered platform technology, Vision AI. The addition would reinforce the Company's mission of expanding AI-powered early detection and preventative health solutions across the globe.
Currently, the Company has identified a promising patented early disease detection technology specializing in the early detection of dementia and is exploring its options to either license the technology globally or potentially acquire the technology altogether. The patented technology combines AI algorithms and hardware based on a 5-minute blood test. Adding the early detection of dementia would expand the offerings in the Company's technology portfolio and enhance the broader vision of the partnership between Avant and Ainnova.
The success of the Company's preventative screening platform involves the deployment of an automated, low-cost retinal imaging device integrated with the Vision AI platform to deliver comprehensive preventive risk screening. Presently, from just two retinal images, blood pressure and some lab test information, the Company's system uses 4 integrated algorithms to assess risks for: (i) cardiovascular disease (CVD), (ii) type 2 diabetes, (iii) liver fibrosis, and (iv) chronic kidney disease (CKD).
Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the potential expansion of its technology portfolio, "This accessible, fast, and scalable solution is designed to support early intervention and targeted treatment strategies, with the ambition of reaching millions of patients globally in the coming years. Adding the early detection of dementia that this patented technology presents us, would go a long way to making us a leader in the industry of early disease detection."
About Ainnova Tech, Inc.
Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce Vision AI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.
About Avant Technologies Inc.
Avant Technologies Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.
More information about Avant can be found at https://avanttechnologies.com
You can also follow us on social media at:
https://twitter.com/AvantTechAI
https://www.linkedin.com/company/avant-technologies-ai
https://www.facebook.com/AvantTechAI
https://www.youtube.com/@AvantTechAI
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.
Contact:
Avant Technologies Inc.
[email protected]
SOURCE: Avant Technologies Inc.
View the original press release on ACCESS Newswire
S.F.Warren--AMWN